|
ABOUT COMPANY
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada.
|
EARNINGS
Gross Profit (TTM): -18357000
Market Capitalization: 1611650000
Operating Margin (TTM): -3.379
PE Ratio: None
PEG Ratio: -0.06
Profit Margin: 0
Revenue Per Share (TTM): 0.468
Revenue (TTM): 19850000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.24
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.547
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -44423000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|